IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.0323
-0.0114 (-26.09%)
At close: Apr 2, 2026, 4:00 PM EDT
0.0296
-0.0027 (-8.36%)
Pre-market: Apr 6, 2026, 5:22 AM EDT
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $2.32 million as of April 6, 2026. Its market cap has decreased by -96.08% in one year.
Market Cap
2.32M
Enterprise Value
-10.22M
1-Year Change
-96.08%
Ranking
Category
Stock Price
$0.03
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $2.32M, a decrease of -99.37%. That is a compound annual growth rate of -68.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 2.32M | -94.70% |
| Dec 31, 2025 | 43.81M | -27.72% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
| Nov 5, 2021 | 369.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.44M |
| Decoy Therapeutics | 3.09M |
| Calidi Biotherapeutics | 2.61M |
| Propanc Biopharma | 2.45M |
| Oragenics | 2.44M |
| Adial Pharmaceuticals | 2.41M |
| Clearmind Medicine | 2.26M |
| Bone Biologics | 2.23M |